Mefloquine induces cell death in prostate cancer cells and provides a potential novel treatment strategy in vivo

Mefloquine (MQ) is currently in clinical use as a prophylactic treatment for malaria. Previous studies have shown that MQ induces oxidative stress in vitro. The present study investigated the anticancer effects of MQ treatment in PC3 cells. The cell viability was evaluated using sulphorhodamine-B (S...

Descripción completa

Detalles Bibliográficos
Autores principales: YAN, KUN-HUANG, LIN, YUNG-WEI, HSIAO, CHI-HAO, WEN, YU-CHING, LIN, KE-HSUN, LIU, CHUNG-CHI, HSIEH, MAO-CHIH, YAO, CHIH-JUNG, YAN, MING-DE, LAI, GI-MING, CHUANG, SHUANG-EN, LEE, LIANG-MING
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2013
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3678863/
https://www.ncbi.nlm.nih.gov/pubmed/23759954
http://dx.doi.org/10.3892/ol.2013.1259

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3678863/
https://www.ncbi.nlm.nih.gov/pubmed/23759954
http://dx.doi.org/10.3892/ol.2013.1259

Ejemplares similares